MoneyWorks4Me

Earum Pharmaceutical - Quaterly Results

05 Nov 2022 Evaluate
Net sales declined -15.54%  to  Rs. 71.14 million from Rs. 84.23 millions.Net profit was down at Rs. 0.37  millions against Rs. 53.99 millions recorded in the corresponding quarter a year ago.The net profit spiraled down by -99.31%.A decline of 0.62 millions was observed in the OP in the quarter ended September 2022 from 54.59 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202209 202109 % Var 202209 202109 % Var 202203 202103 % Var
Sales 71.14 84.23 -15.54 113.93 114.10 -0.15 210.36 410.84 -48.80
Other Income 0.00 22.00 0.00 8.66 22.83 -62.07 77.03 89.32 -13.76
PBIDT 0.62 54.59 -98.86 4.48 21.51 -79.17 32.83 11.71 180.36
Interest 0.00 0.10 0.00 0.00 0.83 0.00 0.82 9.31 -91.19
PBDT 0.62 54.49 -98.86 4.48 20.68 -78.34 32.01 2.40 1233.75
Depreciation 0.25 0.50 -50.00 0.49 0.82 -40.24 1.18 1.23 -4.07
PBT 0.37 53.99 -99.31 3.99 19.86 -79.91 30.83 1.17 2535.04
TAX 0.00 0.00 0.00 0.00 3.28 0.00 8.58 0.29 2858.62
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.37 53.99 -99.31 3.99 16.58 -75.93 22.25 0.88 2428.41
Equity 123.36 123.36 0.00 123.36 123.36 0.00 123.36 61.68 100.00
PBIDTM(%) 0.87 64.81 -98.66 3.93 18.85 -79.14 15.61 2.85 447.54
Peers